We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$325B
AUM Growth
-$10.8B
(-3.2%)
Cap. Flow
-$13.4B
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
22.35%
Holding
3,492
New
145
Increased
887
Reduced
2,282
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$899M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$895M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$597M |
| 4 |
Clarivate
CLVT
|
+$315M |
| 5 |
Mastercard
MA
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$962M |
| 3 |
Intel
INTC
|
+$470M |
| 4 |
Microsoft
MSFT
|
+$449M |
| 5 |
Home Depot
HD
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Financials | 13.11% |
| 3 | Healthcare | 12.33% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Interface
TILE
$2.22B
| $4.93M | ﹤0.01% |
340,864
-66,398
| -16% | -$955K |
|
2202
S&T Bancorp
STBA
$1.79B
| $4.92M | ﹤0.01% |
166,941
-11,296
| -6% | -$333K |
|
|
MORF
2203
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $4.92M | ﹤0.01% |
72,820
-47,472
| -39% | -$2.87M |
|
2204
Standex International
SXI
$4.12B
| $4.89M | ﹤0.01% |
50,094
-1,719
| -3% | -$163K |
|
|
NVEE
2205
DELISTED
NV5 Global
NVEE
| $4.88M | ﹤0.01% |
191,296
-5,744
| -3% | -$141K |
|
2206
Arbutus Biopharma
ABUS
$915M
| $4.87M | ﹤0.01% |
1,119,611
+893,599
| +395% | +$2.98M |
|
|
NTST
2207
NETSTREIT Corp
NTST
$2.1B
| $4.87M | ﹤0.01% |
199,305
-31,725
| -14% | -$801K |
|
|
CHS
2208
DELISTED
Chicos FAS, Inc.
CHS
| $4.86M | ﹤0.01% |
1,031,539
+79,678
| +8% | +$455K |
|
2209
Century Aluminum
CENX
$5.07B
| $4.85M | ﹤0.01% |
372,026
-15,214
| -4% | -$191K |
|
2210
InMode
INMD
$880M
| $4.83M | ﹤0.01% |
+60,644
| New | +$3.7M |
|
2211
ORIX
IX
$43.5B
| $4.83M | ﹤0.01% |
255,600
-35
| -0% | -$644 |
|
2212
Mustang Bio
MBIO
$4.55M
| $4.83M | ﹤0.01% |
2,237
-162
| -7% | -$348K |
|
2213
Universal Corp
UVV
$1.27B
| $4.83M | ﹤0.01% |
100,683
-4,134
| -4% | -$210K |
|
|
FFWM
2214
DELISTED
First Foundation Inc
FFWM
| $4.82M | ﹤0.01% |
193,758
-5,504
| -3% | -$132K |
|
2215
ALX Oncology
ALXO
$290M
| $4.81M | ﹤0.01% |
65,185
-29,752
| -31% | -$1.98M |
|
|
IMGN
2216
DELISTED
Immunogen Inc
IMGN
| $4.81M | ﹤0.01% |
830,023
-64,892
| -7% | -$375K |
|
2217
Autohome
ATHM
$2.62B
| $4.79M | ﹤0.01% |
102,023
+33,000
| +48% | +$1.56M |
|
2218
US Physical Therapy
USPH
$1.22B
| $4.79M | ﹤0.01% |
43,290
-16,674
| -28% | -$1.9M |
|
2219
Alamo Group
ALG
$2.05B
| $4.78M | ﹤0.01% |
32,883
-2,547
| -7% | -$375K |
|
2220
Interparfums
IPAR
$3.94B
| $4.77M | ﹤0.01% |
68,514
-2,324
| -3% | -$170K |
|
|
DCPH
2221
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.77M | ﹤0.01% |
144,679
-7,278
| -5% | -$232K |
|
|
CSII
2222
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.77M | ﹤0.01% |
130,380
-5,750
| -4% | -$215K |
|
2223
Enanta Pharmaceuticals
ENTA
$400M
| $4.76M | ﹤0.01% |
81,546
+390
| +0.5% | +$19.3K |
|
|
VRAY
2224
DELISTED
ViewRay, Inc.
VRAY
| $4.76M | ﹤0.01% |
727,819
-1,050,453
| -59% | -$6.63M |
|
2225
Hanmi Financial
HAFC
$946M
| $4.75M | ﹤0.01% |
252,678
+30,874
| +14% | +$572K |
|
Similar funds
VFT
Nuveen's Q3 2021 Portfolio in Review
As of Q3 2021, Nuveen held 3,492 positions worth $325B, down 3.2% from $335B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen withdrew a net $13.4B in Q3 2021, closing 80 positions and reducing 2,282 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $596M.
- Nuveen's largest Q3 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,810,000 shares worth $596M.
- Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2021, an estimated $899M increase.
- Nuveen's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $1.03B.
- Nuveen fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $219M.
- Nuveen's ten largest holdings make up 22% of its $325B portfolio in Q3 2021.
- Nuveen opened 145 new positions and closed 80 in Q3 2021.
- Nuveen's portfolio value fell 3.2% quarter-over-quarter to $325B.
Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.